These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26490867)

  • 1. Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance.
    Jablonski AM; Lamitina T; Liachko NF; Sabatella M; Lu J; Zhang L; Ostrow LW; Gupta P; Wu CY; Doshi S; Mojsilovic-Petrovic J; Lans H; Wang J; Kraemer B; Kalb RG
    J Neurosci; 2015 Oct; 35(42):14286-306. PubMed ID: 26490867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.
    Lim MA; Selak MA; Xiang Z; Krainc D; Neve RL; Kraemer BC; Watts JL; Kalb RG
    J Neurosci; 2012 Jan; 32(3):1123-41. PubMed ID: 22262909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Cytohesins Protects against Genetic Models of Motor Neuron Disease.
    Zhai J; Zhang L; Mojsilovic-Petrovic J; Jian X; Thomas J; Homma K; Schmitz A; Famulok M; Ichijo H; Argon Y; Randazzo PA; Kalb RG
    J Neurosci; 2015 Jun; 35(24):9088-105. PubMed ID: 26085633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome wide analysis reveals heparan sulfate epimerase modulates TDP-43 proteinopathy.
    Liachko NF; Saxton AD; McMillan PJ; Strovas TJ; Keene CD; Bird TD; Kraemer BC
    PLoS Genet; 2019 Dec; 15(12):e1008526. PubMed ID: 31834878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo.
    Vaccaro A; Patten SA; Aggad D; Julien C; Maios C; Kabashi E; Drapeau P; Parker JA
    Neurobiol Dis; 2013 Jul; 55():64-75. PubMed ID: 23567652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS.
    Thompson ML; Chen P; Yan X; Kim H; Borom AR; Roberts NB; Caldwell KA; Caldwell GA
    Dis Model Mech; 2014 Feb; 7(2):233-43. PubMed ID: 24311730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TDP-43 Inhibits Amyotrophic Lateral Sclerosis-Linked Mutant SOD1 Aggresome Formation in an HDAC6-Dependent Manner.
    Xia Q; Wang H; Zhang Y; Ying Z; Wang G
    J Alzheimers Dis; 2015; 45(2):373-86. PubMed ID: 25720411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 toxicity proceeds via calcium dysregulation and necrosis in aging Caenorhabditis elegans motor neurons.
    Aggad D; Vérièpe J; Tauffenberger A; Parker JA
    J Neurosci; 2014 Sep; 34(36):12093-103. PubMed ID: 25186754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.
    Baskoylu SN; Yersak J; O'Hern P; Grosser S; Simon J; Kim S; Schuch K; Dimitriadi M; Yanagi KS; Lins J; Hart AC
    PLoS Genet; 2018 Oct; 14(10):e1007682. PubMed ID: 30296255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans.
    Estevez AO; Morgan KL; Szewczyk NJ; Gems D; Estevez M
    Neurotoxicology; 2014 Mar; 41(100):28-43. PubMed ID: 24406377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans.
    Vaccaro A; Tauffenberger A; Ash PE; Carlomagno Y; Petrucelli L; Parker JA
    PLoS Genet; 2012 Jul; 8(7):e1002806. PubMed ID: 22792076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression.
    Tortarolo M; Vallarola A; Lidonnici D; Battaglia E; Gensano F; Spaltro G; Fiordaliso F; Corbelli A; Garetto S; Martini E; Pasetto L; Kallikourdis M; Bonetto V; Bendotti C
    J Neurochem; 2015 Oct; 135(1):109-24. PubMed ID: 25940956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maple Syrup Decreases TDP-43 Proteotoxicity in a Caenorhabditis elegans Model of Amyotrophic Lateral Sclerosis (ALS).
    Aaron C; Beaudry G; Parker JA; Therrien M
    J Agric Food Chem; 2016 May; 64(17):3338-44. PubMed ID: 27071850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
    Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
    J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic effects of TDP-43 overexpression in C. elegans.
    Ash PE; Zhang YJ; Roberts CM; Saldi T; Hutter H; Buratti E; Petrucelli L; Link CD
    Hum Mol Genet; 2010 Aug; 19(16):3206-18. PubMed ID: 20530643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
    Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
    Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
    Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.